The Board of Directors of ZoetisTM (NYSE: ZTS), formerly the
animal health business of Pfizer Inc., has declared a second-quarter
dividend payable to holders of the company’s Class A common stock and
Class B common stock of $0.065 per share. The dividend is to be paid on
June 6, 2013, to holders of record on May 1, 2013.
About Zoetis
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on a 60-year
history as the animal health business of Pfizer, Zoetis discovers,
develops, manufactures and markets veterinary vaccines and medicines,
with a focus on both farm and companion animals. The company generated
annual revenues of $4.3 billion in 2012. It has more than 9,300
employees worldwide and a local presence in approximately 70 countries,
including 29 manufacturing facilities in 11 countries. Its products
serve veterinarians, livestock producers and people who raise and care
for farm and companion animals in 120 countries.
DISCLOSURE NOTICE: This news
release contains forward-looking statements, which reflect Zoetis’
current views with respect to business plans or prospects, future
operating or financial performance, and other future events. These
statements are not guarantees of future performance. Forward-looking
statements are subject to risks and uncertainties. If one or more of
these risks or uncertainties materialize, or if management's underlying
assumptions prove to be incorrect, actual results may differ materially
from those contemplated by a forward-looking statement. Forward-looking
statements speak only as of the date on which they are made. Zoetis
expressly disclaims any obligation to update or revise any
forward-looking statement, whether as a result of new information,
future events or otherwise. A further list and description of
risks, uncertainties and other matters can be found in our Annual Report
on Form 10-K for the fiscal year ended December 31, 2012, including in
the sections thereof captioned “Forward-Looking Information and Factors
That May Affect Future Results” and “Item 1A. Risk Factors”, and in our
reports on Form 8-K. These filings and subsequent filings are available
online at www.sec.gov
or on request from Zoetis.
Zoetis
Media:
Bill Price, 1-973-660-5763
william.price@zoetis.com
or
Elinore White, 1-973-401-4044
elinore.y.white@zoetis.com
or
Investors:
Dina Fede, 1-973-660-5441
or
John O’Connor, 1-973-660-6964